Obulytix is set to revolutionize the fight against antimicrobial resistance with its novel phage lysin-based antibiotics. Our team of experts utilizes cutting-edge technology to develop innovative enzyme-based antibiotics that are tailored to the patients needs. Reach out to us for more information.
Valentin Vaerwyckweg 1 Room C4.021 9000 Gent,Belgium
Thank you for contacting us. We will get back to you as soon as possible.
Oops, there was an error sending your message. Please try again later.
Innovative class of enzyme-based antibiotics
Proprietary technology and platform for lysin development
Experienced team of scientists, pharmaceutical experts and business developers
Privacy declaration
BE 0803.351.624